Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2018, Issue -, Pages 1-18
Publisher
Hindawi Limited
Online
2018-03-30
DOI
10.1155/2018/2438598
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- STATs in NK-Cells: The Good, the Bad, and the Ugly
- (2017) Dagmar Gotthardt et al. Frontiers in Immunology
- Progression and metastasis of lung cancer
- (2016) Helmut H. Popper CANCER AND METASTASIS REVIEWS
- The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations
- (2016) S. Novello et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Human innate lymphoid cells
- (2016) Elisa Montaldo et al. IMMUNOLOGY LETTERS
- Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages
- (2016) Lifeng Li et al. INTERNATIONAL JOURNAL OF CANCER
- Dysregulation of regulatory CD56 bright NK cells/T cells interactions in multiple sclerosis
- (2016) Alice Laroni et al. JOURNAL OF AUTOIMMUNITY
- Pleural Effusion of Patients with Malignant Mesothelioma Induces Macrophage-Mediated T Cell Suppression
- (2016) Lysanne A. Lievense et al. Journal of Thoracic Oncology
- STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion
- (2016) D. Gotthardt et al. Cancer Discovery
- CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion
- (2015) Fei Wang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IL15 and T-cell Stemness in T-cell-Based Cancer Immunotherapy
- (2015) K. Pilipow et al. CANCER RESEARCH
- Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
- (2015) Kevin C. Conlon et al. JOURNAL OF CLINICAL ONCOLOGY
- CD56brightCD16−NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+T Cell Proliferation
- (2015) Fabio Morandi et al. JOURNAL OF IMMUNOLOGY
- Pleural neoplastic pathology
- (2015) Georgia Karpathiou et al. RESPIRATORY MEDICINE
- CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients
- (2015) Li Yang et al. Oncotarget
- Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic Stress
- (2015) Meriem Hasmim et al. Frontiers in Immunology
- Trial Watch—Immunostimulation with cytokines in cancer therapy
- (2015) Erika Vacchelli et al. OncoImmunology
- The Proangiogenic Phenotype of Natural Killer Cells in Patients with Non-Small Cell Lung Cancer
- (2015) Antonino Bruno et al. NEOPLASIA
- Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells
- (2014) Jeffrey W. Leong et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Review: Cell Dynamics in Malignant Pleural Effusions
- (2014) Enrico Giarnieri et al. JOURNAL OF CELLULAR PHYSIOLOGY
- CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph
- (2014) P. Carrega et al. JOURNAL OF IMMUNOLOGY
- A Think Tank of TINK/TANKs: Tumor-Infiltrating/Tumor-Associated Natural Killer Cells in Tumor Progression and Angiogenesis
- (2014) Antonino Bruno et al. JNCI-Journal of the National Cancer Institute
- Orchestration of Angiogenesis by Immune Cells
- (2014) Antonino Bruno et al. Frontiers in Oncology
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- Conversion of Peripheral Blood NK Cells to a Decidual NK-like Phenotype by a Cocktail of Defined Factors
- (2013) A. S. Cerdeira et al. JOURNAL OF IMMUNOLOGY
- Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients
- (2013) Maria Ascierto et al. Journal of Translational Medicine
- Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease
- (2013) Carolyn M. Nielsen et al. Frontiers in Immunology
- The Critical Role of the Tumor Microenvironment in Shaping Natural Killer Cell-Mediated Anti-Tumor Immunity
- (2013) Joanna Baginska et al. Frontiers in Immunology
- NK cells from malignant pleural effusions are potent antitumor effectors
- (2013) Paola Vacca et al. OncoImmunology
- Malignant Pleural Effusion
- (2012) Georgios T. Stathopoulos et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Innate Lymphoid Cells: Emerging Insights in Development, Lineage Relationships, and Function
- (2012) Hergen Spits et al. Annual Review of Immunology
- NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation
- (2012) Paola Vacca et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients
- (2012) Yamila S Rocca et al. Innate Immunity
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical implications of pleural effusions in ovarian cancer
- (2012) JOSÉ M. PORCEL et al. RESPIROLOGY
- Macrophages in malignant pleural effusions – alternatively activated tumor associated macrophages
- (2012) Mariusz Kaczmarek et al. Wspolczesna Onkologia-Contemporary Oncology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
- (2011) Sahar M.A. Mahmoud et al. JOURNAL OF CLINICAL ONCOLOGY
- Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay
- (2011) Boris V. Dons'koi et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Decidualization and angiogenesis in early pregnancy: unravelling the functions of DC and NK cells
- (2011) Sandra M. Blois et al. JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Management of the Patient with a Malignant Pleural Effusion
- (2011) John Heffner SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Origin, phenotype and function of human natural killer cells in pregnancy
- (2011) Paola Vacca et al. TRENDS IN IMMUNOLOGY
- TGF-β affects development and differentiation of human natural killer cell subsets
- (2010) David S. J. Allan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Natural killer cells in infection and inflammation of the lung
- (2009) Fiona J. Culley IMMUNOLOGY
- In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
- (2009) Franck Pagès et al. JOURNAL OF CLINICAL ONCOLOGY
- Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells
- (2008) Paolo Carrega et al. CANCER
- Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias
- (2008) Alessandro Moretta et al. IMMUNOLOGICAL REVIEWS
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started